Jan-15
AUTHORS : G. Niklas Norén, Uppsala Monitoring Centre, WHO Collaborating Centre for International Drug Monitoring, Box 1051, SE-75140 Uppsala, Sweden – Email: niklas.noren@who-umc.org
JOURNAL : Drug Safety
REFERENCE: 38(1):87-100
DOI : 10.1007/s40264-014-0251-y